146 related articles for article (PubMed ID: 30181803)
1. Discovery of DEBIC to correlate P-selectin inhibition and DNA intercalation in cancer therapy and complicated thrombosis.
Chen H; Wang W; Zhang X; Liu S; Wang Y; Zhu H; Wu J; Wang Y; Zhao M; Peng S
Oncotarget; 2018 Aug; 9(63):32119-32133. PubMed ID: 30181803
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl 2,2'-[2,2'-(ethane-1,1-diyl)bis(1
Wang Y; Chen H; Zhang X; Gui L; Wu J; Feng Q; Peng S; Zhao M
Int J Nanomedicine; 2018; 13():7835-7844. PubMed ID: 30538462
[TBL] [Abstract][Full Text] [Related]
3. Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors.
Chen H; Lu A; Zhang X; Gui L; Wang Y; Wu J; Feng H; Peng S; Zhao M
Drug Des Devel Ther; 2018; 12():2097-2110. PubMed ID: 30022809
[TBL] [Abstract][Full Text] [Related]
4. Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent.
Zhu H; Wang Y; Song C; Feng Q; Wu J; Zhao S; Gui L; Zhang X; Zhao M; Peng S
Oncotarget; 2018 Jan; 9(1):268-281. PubMed ID: 29416612
[TBL] [Abstract][Full Text] [Related]
5.
Wu J; Zhao M; Wang Y; Wang Y; Zhu H; Zhao S; Gui L; Zhang X; Peng S
Drug Des Devel Ther; 2017; 11():225-239. PubMed ID: 28176928
[TBL] [Abstract][Full Text] [Related]
6. A novel lead of P-selectin inhibitor: Discovery, synthesis, bioassays and action mechanism.
Wu J; Zhao M; Wang Y; Wang Y; Zhu H; Zhao S; Peng S
Bioorg Med Chem Lett; 2016 Oct; 26(19):4631-4636. PubMed ID: 27575475
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles of a New Small-Molecule P-Selectin Inhibitor Attenuate Thrombosis, Inflammation, and Tumor Growth in Two Animal Models.
Feng Q; Wang M; Muhtar E; Wang Y; Zhu H
Int J Nanomedicine; 2021; 16():5777-5795. PubMed ID: 34471352
[TBL] [Abstract][Full Text] [Related]
8. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM): its anti-cancer efficacy and intercalation mechanism identified via multi-model systems.
Wang W; Zhao M; Wang Y; Liu J; Wu J; Kang G; Peng S
Mol Biosyst; 2011 Mar; 7(3):766-72. PubMed ID: 21116565
[TBL] [Abstract][Full Text] [Related]
9. Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin.
Kozlowski EO; Pavao MS; Borsig L
J Thromb Haemost; 2011 Sep; 9(9):1807-15. PubMed ID: 21676168
[TBL] [Abstract][Full Text] [Related]
10. ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.
Xu X; Wang Y; Wu J; Hu X; Zhu H; Zhang X; Wang Y; Gui L; Zhao M; Peng S
Int J Nanomedicine; 2017; 12():4415-4431. PubMed ID: 28652742
[TBL] [Abstract][Full Text] [Related]
11. IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosis.
Wu J; Zhu H; Yang G; Wang Y; Wang Y; Zhao S; Zhao M; Peng S
Oncotarget; 2017 Oct; 8(53):91391-91401. PubMed ID: 29207652
[TBL] [Abstract][Full Text] [Related]
12. Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis.
Li S; Wang Y; Wang F; Wang Y; Zhang X; Zhao M; Feng Q; Wu J; Zhao S; Wu W; Peng S
Int J Nanomedicine; 2015; 10():5273-92. PubMed ID: 26345234
[TBL] [Abstract][Full Text] [Related]
13. Decreased venous thrombosis with an oral inhibitor of P selectin.
Myers DD; Rectenwald JE; Bedard PW; Kaila N; Shaw GD; Schaub RG; Farris DM; Hawley AE; Wrobleski SK; Henke PK; Wakefield TW
J Vasc Surg; 2005 Aug; 42(2):329-36. PubMed ID: 16102635
[TBL] [Abstract][Full Text] [Related]
14. Interaction of mutagenic tryptophan pyrolysate with d(CGATCG)2: intercalation model based on NMR experiments.
Mihara Y; Doi M; Inohara T; Kawamura M; Hamanaka N; Ishida T
Biochem Biophys Res Commun; 1997 Nov; 240(3):803-6. PubMed ID: 9398649
[TBL] [Abstract][Full Text] [Related]
15. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation.
Nelson RM; Cecconi O; Roberts WG; Aruffo A; Linhardt RJ; Bevilacqua MP
Blood; 1993 Dec; 82(11):3253-8. PubMed ID: 7694675
[TBL] [Abstract][Full Text] [Related]
16. P-selectin can promote thrombus propagation independently of both von Willebrand factor and thrombospondin-1 in mice.
Prakash P; Nayak MK; Chauhan AK
J Thromb Haemost; 2017 Feb; 15(2):388-394. PubMed ID: 27943541
[TBL] [Abstract][Full Text] [Related]
17. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
Oostingh GJ; Pozgajova M; Ludwig RJ; Krahn T; Boehncke WH; Nieswandt B; Schön MP
Haematologica; 2007 Apr; 92(4):502-12. PubMed ID: 17488661
[TBL] [Abstract][Full Text] [Related]
18. Anti-thrombosis effect of LRRFIP1 shRNA lentivirus in a mouse model of deep vein thrombosis.
Yin X; Wu S; Wang Z; Wang Y; Du Q; Wang A
Thromb Res; 2013 Jul; 132(1):127-31. PubMed ID: 23751182
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis.
Bedard PW; Clerin V; Sushkova N; Tchernychev B; Antrilli T; Resmini C; Keith JC; Hennan JK; Kaila N; Debernardo S; Janz K; Wang Q; Crandall DL; Schaub RG; Shaw GD; Carter LL
J Pharmacol Exp Ther; 2008 Feb; 324(2):497-506. PubMed ID: 18024786
[TBL] [Abstract][Full Text] [Related]
20. Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship.
Hassan OM; Kubba A; Tahtamouni LH
Anticancer Agents Med Chem; 2023; 23(11):1336-1348. PubMed ID: 36847231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
